Proud to announce our new publication in PNAS showcasing the power of our science to engineer proteases. Congratulations to Liliana Sanmarco, Ph.D., Senior Scientist 2, who led this research!
See publication here: https://t.co/cZZ4X1qhtN
#WeAreSeismic#SeismonautsInAction
Our newest paper studying immunosuppressive astrocyte-GBM interactions using RABID-seq is out in @Nature today! Congrats to Brian Andersen and @CamiloFaustAkl!
https://t.co/X9mq5dhw1v
Our study on glioblastoma-associated immunoregulatory astrocytes is out in @Nature today by @CamiloFaustAkl! We identified GBM-derived IL-11 as a regulator of TRAIL+ astrocytes, which limit anti-tumor T cell responses via apoptosis.
https://t.co/MogfcvWu8Z
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation
https://t.co/FHpQ6a4230
This new review discusses how the AHR - once avoided in drug development - is now being targeted for inflammatory disorders, cancer and infectious diseases
📢 The findings behind Xenon therapy for AD are now published: https://t.co/Qqg4v3U304. The study explores Xenon’s effects in multiple AD mouse models, highlighting microglia modulation & its therapeutic potential. #AlzheimersResearch#Microglia#SciTransMed.
Nothing more rewarding than seeing the progress and success of your former students! @NZanluqui just gave a fantastic talk while receiving the Norman P. Salzman Memorial awards at the @NIH@FNIH_Org ! Congratulations Nage ….you deserve it all! 🎉👏🍾🍾👏👏🎉🎉#neuroimmunology
So proud of our former student @NZanluqui for being awarded The Norman P. Salzman Memorial Awards in Basic and Clinical Virology 😱🎉🎉 congrats Nagela. Well deserved ! https://t.co/NIlqlyqbFe